SIGA Technologies, Inc.

NGM: SIGA

Live Quote

📈 ZcoreAI Score

Our AI model analyzes SIGA Technologies, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get SIGA Z-Score →

About SIGA Technologies, Inc.

Healthcare Drug Manufacturers - Specialty & Generic

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

📊 Fundamental Analysis

SIGA Technologies, Inc. demonstrates exceptional profitability, with a profit margin of 24.6%.

The company recently reported -95.3% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is 11.2%, which suggests room for improvement in capital utilization.

At a current price of $4.36, SIGA currently trades near the bottom of its 52-week range (1%), indicating potential value or weakness (Range: $4.33 - $9.62).

💰 Valuation Insight

SIGA trades at a 45.5% discount (PE: 13.63), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

✅ Profit Margin Excellent

✅ Debt/Equity Excellent

🔴 Revenue Growth Weak

🔴 Return on Equity Weak

⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap

$312.37M

Trailing P/E

13.63

Forward P/E

2.97

Beta (5Y)

1.06

52W High

$9.62

52W Low

$4.33

Avg Volume

620K

Day High

Day Low

Get SIGA Z-Score on Dashboard 🚀